National Institute for Health and Care Excellence

Spectra Optia for automatic red blood cell exchange in people with sickle cell disease

The Spectra Optia Apheresis System (Terumo BCT) is an apheresis and cell collection platform which can be used in the treatment of sickle cell disease. The purpose of this evaluation is to assess the ...
technologynetworks

Terumo Blood and Cell Technologies Supports Expanded Access to Rare Disease Therapies in ...

In a significant step toward expanding treatment access for people with rare and chronic diseases in Latin America (LATAM), Terumo Blood and Cell Technologies (Terumo BCT), announced that its Spectra ...